文献速递甲状腺与颈部外科围术期管理与 ERAS

老年原发性甲状旁腺功能亢进:手术较非手术降低心血管不良结局

Adverse Cardiovascular Outcomes Among Older Adults With Primary Hyperparathyroidism Treated With Parathyroidectomy Versus Nonoperative Management.
PubMed 文献 · Ann Surg · 2022-08-25

基于2006–2017年Medicare人群的纵向队列研究,比较老年原发性甲状旁腺功能亢进患者接受甲状旁腺切除术与非手术管理的 CV 结局。多变量分析显示手术与较低 MACE、CV 病相关住院及 CV 住院相关死亡风险相关,10 年绝对风险降低虽小但显著。

要点

  • 老年 PHPT 患者接受甲状旁腺切除术与较低 MACE 风险相关(HR 0.92)。
  • 手术亦与较低 CV 病相关住院(HR 0.89)及 CV 住院相关死亡(HR 0.76)相关。
  • 10 年绝对风险降低幅度较小,决策需结合预期寿命。

核心结论

  • 在老年 PHPT 患者中,与非手术管理相比,甲状旁腺切除术与长期不良 CV 结局发生率较低相关。

研究设计与样本

  • 基于人群的纵向队列研究,纳入 2006–2017 年诊断为 PHPT 的 Medicare 受益人 210,206 例。

主要发现

  • 63,136 例(30.0%)在诊断后 1 年内接受甲状旁腺切除术,147,070 例(70.0%)非手术管理。
  • 未调整 MACE 发生率手术组 10.0%(平均随访 59.1 个月,SD 35.6),非手术组 11.5%(平均随访 54.1 个月,SD 34.0)。
  • 多变量分析:手术 vs 非手术 MACE HR 0.92(95%CI 0.90–0.94),CV 病相关住院 HR 0.89(95%CI 0.87–0.91),CV 住院相关死亡 HR 0.76(95%CI 0.71–0.81)。
  • 10 年调整绝对风险降低:MACE 1.7%(95%CI 1.3%–2.1%),CV 病相关住院 2.5%(95%CI 2.1%–2.9%),CV 住院相关死亡 1.4%(95%CI 1.2%–1.6%)。

临床怎么用

  • 对预期寿命较长的老年 PHPT 患者,甲状旁腺切除术可作为降低长期 CV 风险的考虑因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The authors sought to compare the incidence of adverse cardiovascular (CV) events in older adults with primary hyperparathyroidism (PHPT) treated with parathyroidectomy versus nonoperative management. BACKGROUND: PHPT is a common endocrine disorder that is associated with increased CV mortality, but it is not known whether parathyroidectomy reduces the incidence of adverse CV events. METHODS: The authors conducted a population-based, longitudinal cohort study of Medicare beneficiaries diagnosed with PHPT (2006-2017). Multivariable, inverse probability weighted Cox proportional hazards regression was used to determine the associations of parathyroidectomy with major adverse cardiovascular events (MACEs), CV disease-related hospitalization, and CV hospitalization-associated mortality. RESULTS: The authors identified 210,206 beneficiaries diagnosed with PHPT from 2006 to 2017. Among 63,136 (30.0%) treated with parathyroidectomy and 147,070 (70.0%) managed nonoperatively within 1 year of diagnosis, the unadjusted incidence of MACE was 10.0% [mean follow-up 59.1 (SD 35.6) months] and 11.5% [mean follow-up 54.1 (SD 34.0) months], respectively. In multivariable analysis, parathyroidectomy was associated with a lower incidence of MACE [hazard ratio (HR): 0.92; 95% confidence interval (95% CI): 0.90-0.94], CV disease-related hospitalization (HR: 0.89; 95% CI: 0.87-0.91), and CV hospitalization-associated mortality (HR: 0.76; 95% CI: 0.71-0.81) compared to nonoperative management. At 10 years, parathyroidectomy was associated with adjusted absolute risk reduction for MACE of 1.7% (95% CI: 1.3%-2.1%), for CV disease-related hospitalization of 2.5% (95% CI: 2.1%-2.9%), and for CV hospitalization-associated mortality of 1.4% (95% CI: 1.2%-1.6%). CONCLUSIONS: In this large, population-based cohort study, parathyroidectomy was associated with a lower long-term incidence of adverse CV outcomes when compared with nonoperative management for older adults with PHPT, which is relevant to surgical decision making for patients with a long life expectancy.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Seib CD, Meng T, Cisco RM, et al. Adverse Cardiovascular Outcomes Among Older Adults With Primary Hyperparathyroidism Treated With Parathyroidectomy Versus Nonoperative Management. Ann Surg. 2022. PMID: 36005546. doi:10.1097/SLA.0000000000005691

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。